HomeInsightsPE

Windlas Biotech Ltd PE Ratio

Windlas Biotech Ltd PE Ratio

stocks purchased

₹ 1.0 Cr

Volume Transacted

(Nov 29, 2024)

stocks purchased

9.4 K

Stocks Traded

(Nov 29, 2024)

Last Updated on: Nov 30, 2024

Image

Windlas Biotech Ltd

NSE: WINDLAS

PE

37.4

Last updated on: Nov 30, 2024

Key Highlights

  • The P/E Ratio of Windlas Biotech Ltd is 37.4 as of 30 Nov 09:59 AM .
  • The P/E Ratio of Windlas Biotech Ltd changed from 12 on March 2022 to 18.3 on March 2024 . This represents a CAGR of 15.10% over 3 years.
  • The Latest Trading Price of Windlas Biotech Ltd is ₹ 1094 as of 29 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Windlas Biotech Ltd

No data available

Company Fundamentals for Windlas Biotech Ltd

No data available

Image

Windlas Biotech Ltd

NSE: WINDLAS

Share Price

₹ 1094.75

52.45 (5.03%)

stock direction

Last updated on: Nov 29, 2024

Market Price of Windlas Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Windlas Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
29 Nov 20241094.75
28 Nov 20241042.3
27 Nov 20241014.7
26 Nov 20241024.3
25 Nov 20241041.85
22 Nov 2024962.45
21 Nov 2024925.35
19 Nov 2024957.95
18 Nov 2024984.95
14 Nov 20241023.95

SWOT Analysis Of Windlas Biotech Ltd

Strength

5

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Windlas Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Windlas Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Windlas Biotech Ltd372,288
Sun Pharmaceuticals Industries Ltd384,27,478
Divis Laboratories Ltd891,63,822
Cipla Ltd261,23,920
Torrent Pharmaceuticals Ltd641,12,592
Mankind Pharma Ltd481,02,660

Key Valuation Metric of Windlas Biotech Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Windlas Biotech Ltd

No data available

* All values are in crore

Historical Revenue of Windlas Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Windlas Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Windlas Biotech Ltd

No data available

* All values are in crore

Historical Dividend Payout of Windlas Biotech Ltd

No data available

* All values are in %

About Windlas Biotech Ltd

  • Windlas Biotech Limited (formerly known as Windlas Biotech Private Limited) was incorporated in 2001.
  • The Company converted from a Private Limited Company to a Public Limited Company and the name of the Company was changed to Windlas Biotech Limited'.
  • A fresh Certificate of Incorporation dated April 15, 2021, granted by the Registrar of Companies, Uttarakhand at Dehradun. The Company is engaged in manufacturing and trading of pharmaceutical products.
  • TheIR manufacturing facilities are located at Dehradun in Uttarakhand.
  • It also has a sales force and distribution network spread across 14 states.

Windlas Biotech Ltd News Hub

News

Windlas Biotech consolidated net profit rises 11.68% in the June 2024 quarter

Net profit of Windlas Biotech rose 11.68% to Rs 13.48 crore in the quarter ended June 2024...

Read more

2024-08-13 00:00:00

News

Windlas Biotech to declare Quarterly Result

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 13 August ...

Read more

2024-08-03 00:00:00

News

Windlas Biotech schedules AGM

Windlas Biotech announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

2024-09-03 00:00:00

News

Windlas Biotech to hold AGM

Windlas Biotech announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

2024-09-03 00:00:00

News

Windlas Biotech consolidated net profit rises 11.62% in the September 2024 quarter

Net profit of Windlas Biotech rose 11.62% to Rs 15.66 crore in the quarter ended September...

Read more

2024-11-12 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Windlas Biotech Ltd

What is the current PE Ratio of Windlas Biotech Ltd?

The Current PE Ratio of Windlas Biotech Ltd is 37.36 as on 30 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 30 Nov 2024.

What was the PE Ratio of Windlas Biotech Ltd last year?

The PE Ratio of Windlas Biotech Ltd was 11.06 last year, now the PE ratio is 37.36, showing a year-on-year growth of 237.8%.

What does the PE Ratio of Windlas Biotech Ltd indicate about its stock?

The PE Ratio of Windlas Biotech Ltd is 37.36. This ratio indicates that investors are willing to pay 37.36 times the earnings per share for each share of Windlas Biotech Ltd.

What is the PE Ratio Growth of Windlas Biotech Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Windlas Biotech Ltd grew by 237.8% whereas, the EPS ratio grew by 15.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading starting at just

Rs. 249*